Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Enliven Therapeutics (ELVN) Q3 2022 Earnings
ELVN
25
Oct
Expected
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-2.24
-1.59
-0.93
-0.28
Details
Expected EPS
-0.2808
Actual EPS
-0.72
Surprise EPS
-0.44
Surprise Percent
+156.41%
Description
Enliven Therapeutics (ELVN) has reported earnings of -0.72 per share for Q3 2022.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login